It’s better to be safe than sorry!
CDC warns public as RSV cases rising more than double the pre-Covid figures
In a recent article published by CNN Health, the US Centers for Disease Control and Prevention is warning physicians that cases of respiratory syncytial virus, known as RSV, are rising in the Southeast — and that regional increase may portend a rise in the rest of the United States in the next two to three months.
According to the CDC Health Alert Network advisory, the RSV cases rising have predicted the beginning of RSV season nationally. With RSV cases rising activity spreading north and west over the following 2–3 months. The notices are communications to physicians, and other health care providers across the United States.
RSV is a virus that attacks the lower lungs. In babies, who have tiny airways, RSV can cause the lungs to fill with mucus, making it difficult to breathe. RSV cases rising is the leading cause of hospitalization in the United States for infants under 1 year of age. RSV cases rising can also be serious for seniors. RSV hospitalizes an estimated 60,000 to 160,000 adults age 60 and older annually.
Read Also:Rising cases in Southeast could be start of U.S. RSV season, CDC warns
RSV cases rising began in the South in late July, and have more than doubled over the past month, according to CDC data, though they are nowhere near last season’s peak. Last year’s season of RSV cases rising in the United States was one of the worst in memory for many physicians.
RSV cases rising encourage doctors to administer new immunizations for babies and adults over the age of 60 as soon as they become available. Two new RSV vaccines for seniors are available now and will surely help the RSV cases rising to stop.
RSV cases rising urge new immunization for babies and young children. The RSV cases rising encourage doctors to get ready to give the shot a new monoclonal antibody called Beyfortus as soon as it’s available in early October.